Korea will begin reimbursing Servier's targeted cancer drug Tibsovo (ivosidenib) from Nov. 1, expanding treatment options for ...
Servier Korea’s targeted therapy Tibsovo tablets, whose active ingredient is ivosidenib, will receive national health ...
According to DelveInsight's analysis, the chondrosarcoma market size was found to be ~USD 15 million in the 7MM in 2025, and it is projected to grow at a CAGR of 16% during 2026–2036. Among the 7MM, ...
A new study shows the PET radioligand AG-120 binds specifically to both wild-type and mutant IDH1, but measured affinities ...
ಕ್ಯಾನ್ಸರ್ ಚಿಕಿತ್ಸೆಯ ದುಬಾರಿ ವೆಚ್ಚದಿಂದ ಕಂಗೆಟ್ಟಿರುವ ರೋಗಿಗಳಿಗೆ ಕೇಂದ್ರ ಸರ್ಕಾರದಿಂದ ಕೊಂಚ ನಿರಾಳತೆಯ ಸುದ್ದಿಯೊಂದಿದೆ! 137 ಜೀವರಕ್ಷಕ ...
The ministry said the measure on TMR for anti-cancer drugs aims to control excessive trade margins in the distribution and retail channels while safeguarding legitimate manufacturers' revenues and ...
Manufacturers have been directed to inform the NPPA of their revised prices within seven days of publication of the Gazette notification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results